USP

Dimethyl sulfoxide

Name: Dimethyl sulfoxide
Brand: USP
Price: 199000 HUF

United States Pharmacopeia (USP) Reference Standard

Synonym(s):

DMSO

Slide 1 of 1

Select a Size

3 G

HUF 199,000.00

Please contact Customer Service for Availability

Request a Bulk Order

About This Item

Linear Formula:

(CH₃)₂SO

CAS Number:

67-68-5

Molecular Weight:

78.13

Beilstein:

506008

MDL number:

MFCD00002089

UNSPSC Code:

41116107

PubChem Substance ID:

329749622

NACRES:

NA.24

Key Documents

View All Documentation

grade

pharmaceutical primary standard

vapor density

2.7 (vs air)

vapor pressure

0.42 mmHg ( 20 °C)

autoignition temp.

573 °F

expl. lim.

42 %, 63 °F

manufacturer/tradename

USP

availability

not available in (Sales restrictions may apply)

refractive index

n20/D 1.479 (lit.)

bp

189 °C (lit.)

mp

16-19 °C (lit.)

density

1.10 g/mL (lit.)

application(s)

pharmaceutical (small molecule)

format

neat

SMILES string

CS(C)=O

InChI

1S/C2H6OS/c1-4(2)3/h1-2H3

InChI key

IAZDPXIOMUYVGZ-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

Related Categories

Analytical Reference Materials for Pharma QC

Certified Reference Materials

Pharmacopeia & Metrological Institute Standards

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item	D2050000	PHR1309	1.37117
USP 1211006 Dimethyl sulfoxide	D2050000 Dimethyl sulfoxide	Supelco PHR1309 Dimethyl Sulfoxide	SAFC 1.37117 Dimethyl sulfoxide
manufacturer/tradename USP	manufacturer/tradename EDQM	manufacturer/tradename -	manufacturer/tradename -
grade pharmaceutical primary standard	grade pharmaceutical primary standard	grade certified reference material, pharmaceutical secondary standard	grade -
application(s) pharmaceutical (small molecule)	application(s) pharmaceutical (small molecule)	application(s) pharmaceutical (small molecule)	application(s) liquid formulation parenterals pharma/biopharma processes pharmaceutical semi-solid formulation
format neat	format neat	format neat	format -
vapor density 2.7 (vs air)	vapor density 2.7 (vs air)	vapor density -	vapor density 2.7 (vs air)
vapor pressure 0.42 mmHg ( 20 °C)	vapor pressure 0.42 mmHg ( 20 °C)	vapor pressure -	vapor pressure 0.42 mmHg ( 20 °C)

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Dimethyl sulfoxide USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as:

Dimethyl Sulfoxide Irrigation
Dimethyl Sulfoxide Gel
Dimethyl Sulfoxide Topical Solution
Methylsulfonylmethane

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.

Other Notes

Sales restrictions may apply.

Disclaimer

Supercools easily and remelts slowly at room temperature. Solidified product can be re-liquified by warming to room temperature without detriment to the product.

comparable product

Product No.

Description

Pricing

PHR1309

Dimethyl Sulfoxide, Pharmaceutical Secondary Standard; Certified Reference Material

Storage Class Code

11 - Combustible Solids

WGK

WGK 1

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Dimethyl Sulfoxide Topical Solution

United States Pharmacopeia and National Formulary

United States Pharmacopeia, 1414-1414 (2020)

Methylsulfonylmethane

United States Pharmacopeia and National Formulary

United States Pharmacopeia, 32(3), 5097-5097 (2020)

Identification and characterisation of small molecule inhibitors of feline coronavirus replication.

Phillip McDonagh et al.

Veterinary microbiology, 174(3-4), 438-447 (2014-12-04)

Feline infectious peritonitis (FIP), a feline coronavirus (FCoV) induced disease, is almost invariably fatal with median life expectancy measured in days. Current treatment options are, at best, palliative. The objectives of this study were to evaluate a panel of nineteen

Foretinib is effective therapy for metastatic sonic hedgehog medulloblastoma.

Claudia C Faria et al.

Cancer research, 75(1), 134-146 (2014-11-14)

Medulloblastoma is the most common malignant pediatric brain tumor, with metastases present at diagnosis conferring a poor prognosis. Mechanisms of dissemination are poorly understood and metastatic lesions are genetically divergent from the matched primary tumor. Effective and less toxic therapies

Both leukaemic and normal peripheral B lymphoid cells are highly sensitive to the selective pharmacological inhibition of prosurvival Bcl-2 with ABT-199.

S L Khaw et al.

Leukemia, 28(6), 1207-1215 (2014-01-10)

Overexpression of the prosurvival protein Bcl-2 marks many B-lymphoid malignancies and contributes to resistance to many commonly used chemotherapeutic agents. The first effective BH3 mimetic inhibitors of Bcl-2, ABT-737 and navitoclax, also target Bcl-xL, causing dose-limiting thrombocytopenia. This prompted the

View All Related Papers

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service